Hoshi Iryo-Sanki (7634) Q2 2025 earnings summary

Executive summary

• Revenue for the six months ended September 30, 2024, increased by 4.6% year-over-year to ¥7,285 million, with operating profit up 0.2% to ¥880 million and net profit attributable to shareholders up 0.4% to ¥622 million.

• The business continued to prioritize stable supply of products and services, safety, and social responsibility in the medical, nursing, and welfare sectors.

Financial highlights

• Gross profit rose to ¥3,667 million from ¥3,507 million year-over-year.

• Operating profit was ¥880 million, up 0.2% year-over-year; ordinary profit was ¥924 million, up 1.9%.

• Net profit attributable to shareholders was ¥622 million, up 0.4% year-over-year.

• EPS for the period was ¥199.70, compared to ¥199.16 in the prior year.

• Comprehensive income decreased by 11.0% year-over-year to ¥791 million.

Outlook and guidance

• Full-year revenue forecast remains unchanged at ¥15,000 million, with operating profit of ¥2,010 million and net profit attributable to shareholders of ¥1,420 million.

• Annual dividend forecast is ¥70 per share, unchanged from the previous year.